Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88258605 |
Registration Number | 5833012 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Stephen R. Barrese, Esq. |
Attorney Docket Number | 587-950 |
Law Office Assigned | L90 |
Employee Name | ANKRAH, NAAKWAMA S |
2019-01-11 | Application Filed |
2019-05-28 | Published for Opposition |
2019-08-13 | Location: PUBLICATION AND ISSUE SECTION |
2019-08-13 | Status: Live/Registered |
2019-08-13 | Trademark Registered |
2019-08-13 | Transaction Date |
Owner: | ![]() |
Entity Statement | limited company (ltd.) |
Address | 107, Cheomdan-daero, Yeonsu-gu, Incheon KR 21987 |
Legal Entity Type | |
Legal Entity State | KR |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis |
GS0051 | Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2019-01-15 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-02-02 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2019-03-22 | 3 DOCK D:Assigned to Examiner |
SUSPENSION LETTER WRITTEN | 2019-03-22 | 4 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2019-03-22 | 5 GNSL F:First Action |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-03-22 | 6 GNS3 O:Outgoing Correspondence |
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2019-04-09 | 7 ERSI I:Incoming Correspondence |
ASSIGNED TO LIE | 2019-04-14 | 8 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-04-16 | 9 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-04-16 | 10 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-04-17 | 11 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-05-08 | 12 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2019-05-28 | 13 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-05-28 | 14 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2019-08-13 | 15 R.PR A:Allowance for Publication |
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2024-08-13 | 16 REM1 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.